Rwanda Recalls Ketoconazole Oral Tablets Over Safety Concerns
, The National Agency for Food and Drug Administration and Control is notifying the Public that Rwanda FDA governing pharmacovigilance for pharmaceutical products and medical devices, has conducted a deep analysis and concluded that “Ketoconazole Oral tablets have higher risks of liver injury than benefits when treating fungal infections”. Hence the authority withdrew all the […]
